SI-BONE, Inc. (SIBN): Price and Financial Metrics


SI-BONE, Inc. (SIBN)

Today's Latest Price: $22.94 USD

1.01 (4.61%)

Updated Nov 27 1:00pm

Add SIBN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

SIBN Stock Summary

  • SIBN's went public 2.12 years ago, making it older than merely 4.86% of listed US stocks we're tracking.
  • Of note is the ratio of SI-BONE Inc's sales and general administrative expense to its total operating expenses; 76.22% of US stocks have a lower such ratio.
  • SIBN's price/sales ratio is 10.45; that's higher than the P/S ratio of 85.65% of US stocks.
  • Stocks that are quantitatively similar to SIBN, based on their financial statements, market capitalization, and price volatility, are ACRX, IGC, CDXC, KIDS, and CUTR.
  • Visit SIBN's SEC page to see the company's official filings. To visit the company's web site, go to si-bone.com.

SIBN Stock Price Chart Interactive Chart >

Price chart for SIBN

SIBN Price/Volume Stats

Current price $22.94 52-week high $26.41
Prev. close $21.93 52-week low $7.20
Day low $21.93 Volume 99,800
Day high $22.94 Avg. volume 232,598
50-day MA $22.76 Dividend yield N/A
200-day MA $18.43 Market Cap 742.36M

SI-BONE, Inc. (SIBN) Company Bio


SI-BONE, Inc. engages in the development of invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded on April 2008 by Mark A. Reiley and Jeffrey W. Dunn in and is headquartered in San Jose, CA.


SIBN Latest News Stream


Event/Time News Detail
Loading, please wait...

SIBN Latest Social Stream


Loading social stream, please wait...

View Full SIBN Social Stream

Latest SIBN News From Around the Web

Below are the latest news stories about SI-BONE Inc that investors may wish to consider to help them evaluate SIBN as an investment opportunity.

The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) (the first subject has been dosed in a Phase 3 trial evaluating etrasimod for the potential treatment of moderately to severely active ulcerative colitis) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) (announced a deal with Russia for 100 million doses of Sputnik-V vaccine against the coronavirus) Fortress Biotech (NASDAQ: FBIO ) Guardant Health Inc (NASDAQ: GH ) Immunovant Inc (NASDAQ: IMVT ) Insmed Incorporated (NASDAQ: INSM ) InVitae Corp (NYSE: NVTA ) ...

Benzinga | September 17, 2020

The Daily Biotech Pulse: Moderna Expands Into Switzerland, Tiziana To Spin Off Testing Unit, Metacrine IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Avidity Biosciences Inc (NASDAQ: RNA ) Beigene Ltd (NASDAQ: BGNE ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Denali Therapeutics Inc (NASDAQ: DNLI ) Fate Therapeutics Inc (NASDAQ: FATE ) Guardant Health Inc (NASDAQ: GH ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunovant Inc (NASDAQ: IMVT ) InVitae Corp (NYSE: NVTA ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS ) ( announced a positive late-stage readout for ganaxolone) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Myokardia Inc (NASDAQ: MYOK ) Novocure Ltd (NASDAQ: NVCR ) Outset Medical Inc (NASDAQ: OM ) (more than...

Benzinga | September 16, 2020

The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) 10X Genomics Inc (NASDAQ: TXG ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Avidity Biosciences Inc (NASDAQ: RNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Denali Therapeutics Inc (NASDAQ: DNLI ) Guardant Health Inc (NASDAQ: GH ) Immunomedics, Inc. (NASDAQ: IMMU ) - announced a deal to be bought by Gilead Sciences, Inc. (NASDAQ: GILD ) for $21 billion Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) (announced the appointment of Susan Kim as CFO, effective Sept. 28) Shockwave Medical Inc (NASDAQ: SWAV ) SI-Bone Inc (NASDAQ...

Benzinga | September 15, 2020

SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q2 2020 Results - Earnings Call Transcript

SI-BONE, Inc. (SIBN) Q2 2020 Earnings Conference Call Aug 03, 2020, 04:30 PM ET Company Participants Matt Bacso - The Gilmartin Group Jeff Dunn - President & CEO Laura Francis - CFO & COO Conference Call Participants David Lewis - Morgan Stanley Kyle Rose - Canaccord David Turkaly - JMP...

SA Transcripts on Seeking Alpha | August 3, 2020

SI-BONE to Present at the 40th Annual Canaccord Genuity Growth Conference

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcoming 40th Annual Canaccord Genuity Growth Conference that is being held virtually.SI-BONE’s management is scheduled for a live Fireside Chat on Wednesday, August 12, 2020 at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time. Interested parties may access a live and archived webcast of the event on the “Investors” section of the company’s website at: www.si-bone.com. About SI-BONESI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System.  Studies have shown that the SI j...

Yahoo | July 30, 2020

Read More 'SIBN' Stories Here

SIBN Price Returns

1-mo 9.39%
3-mo 5.13%
6-mo 24.81%
1-year 28.95%
3-year N/A
5-year N/A
YTD 6.70%
2019 2.92%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching SIBN

Here are a few links from around the web to help you further your research on SI-BONE Inc's stock as an investment opportunity:

SI-BONE Inc (SIBN) Stock Price | Nasdaq
SI-BONE Inc (SIBN) Stock Quote, History and News - Yahoo Finance
SI-BONE Inc (SIBN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8172 seconds.